Explore 2025's groundbreaking scientific discoveries: the MoM-z14 galaxy, personalised CRISPR therapy, regenerative medicine, ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...
Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...
An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...
Morning Overview on MSN
New genetic map shows how thousands of genes drive disease
For decades, geneticists have known that most common illnesses are not caused by a single rogue gene but by intricate ...
Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...
The region helped invent cell and gene therapy. Now, there’s an opportunity to reengineer it so more people can actually access it, a life sciences leader writes.
RCSI – Medical University of Bahrain visited the Cell Therapy Center (CTC) at the University of Jordan ...
As the pharma industry turns away, parents of children with ultra-rare diseases step in to advance drug development.
In 2025, UCL scientists made breakthroughs in Huntington’s disease, cancer and sight loss, revealed the Sun’s south pole and ...
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback